Cardiovascular Support: Good for Your Heart Your heart is constantly working, and it relies heavily on fatty acids for fuel
The studys limitations include its reliance on lifestyle intervention adherence, and a follow-up period limited to 68 weeks
Study Data (84,990 patients): Patients on GLP-1 agonists had lower rates of: - Acute myocardial infarction - Atrial fibrillation - Stroke - Kidney failure Benefits were confirmed even in patients already taking SGLT2 inhibitors
Combined with the reduced caloric intake many patients experience due to appetite suppression, patients may notice increased sensitivity and dryness, says Puza
BEATRIZ DE LA CALLE Head of Commercial Analytics Qualicaps, Leading Pharmaceutical Company www.qualicaps.com/ We partnered with MarketsandMarkets for an assessment study on hard empty capsules
A randomized, double-blind, controlled study in humans